1. Highly Antiproliferative Latonduine and Indolo[2,3- c ]quinoline Derivatives: Complex Formation with Copper(II) Markedly Changes the Kinase Inhibitory Profile.
- Author
-
Wittmann C, Bacher F, Enyedy EA, Dömötör O, Spengler G, Madejski C, Reynisson J, and Arion VB
- Subjects
- Animals, Antineoplastic Agents chemistry, Antineoplastic Agents metabolism, Antineoplastic Agents pharmacology, Antineoplastic Agents therapeutic use, Binding Sites, Cattle, Cell Line, Tumor, Cell Proliferation drug effects, Coordination Complexes metabolism, Coordination Complexes pharmacology, Coordination Complexes therapeutic use, Crystallography, X-Ray, DNA chemistry, DNA metabolism, Humans, Indoles chemistry, Molecular Conformation, Molecular Docking Simulation, Protein Kinase Inhibitors metabolism, Protein Kinase Inhibitors pharmacology, Protein Kinase Inhibitors therapeutic use, Protein Kinases chemistry, Protein Kinases metabolism, Solubility, Structure-Activity Relationship, Coordination Complexes chemistry, Copper chemistry, Heterocyclic Compounds, 3-Ring chemistry, Protein Kinase Inhibitors chemistry, Quinolines chemistry
- Abstract
A series of latonduine and indoloquinoline derivatives HL
1 - HL8 and their copper(II) complexes ( 1-8 ) were synthesized and comprehensively characterized. The structures of five compounds ( HL6 , [CuCl(L1 )(DMF)]·DMF , [CuCl(L2 )(CH3 OH)] , [CuCl(L3 )]·0.5H2 O , and [CuCl2 (H2 L5 )]Cl·2DMF ) were elucidated by single crystal X-ray diffraction. The copper(II) complexes revealed low micro- to sub-micromolar IC50 values with promising selectivity toward human colon adenocarcinoma multidrug-resistant Colo320 cancer cells as compared to the doxorubicin-sensitive Colo205 cell line. The lead compounds HL4 and 4 as well as HL8 and 8 induced apoptosis efficiently in Colo320 cells. In addition, the copper(II) complexes had higher affinity to DNA than their metal-free ligands. HL8 showed selective inhibition for the PIM-1 enzyme, while 8 revealed strong inhibition of five other enzymes, i.e., SGK-1, PKA, CaMK-1, GSK3β, and MSK1, from a panel of 50 kinases. Furthermore, molecular modeling of the ligands and complexes showed a good fit to the binding pockets of these targets.- Published
- 2022
- Full Text
- View/download PDF